Tango Therapeutics, Inc. (TNGX) Net margin 2020–2025
Tango Therapeutics, Inc. (TNGX) net profit margin by fiscal year — reported net income divided by reported revenue.
-162.9%FY2025 · since FY2020: -678.8% → -162.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -162.9% | +146.9 pp |
| FY2024 | -309.7% | -31.3 pp |
| FY2023 | -278.4% | +156.7 pp |
| FY2022 | -435.1% | -277.9 pp |
| FY2021 | -157.2% | +521.6 pp |
| FY2020 | -678.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice